Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma

Journal of Surgical Oncology

Volumn 107, Issue 2, 2013, Pages 105-110

  Zeng, Zhao Lin ^a   Li, Fu Jun ^a   Gao, Feng ^a   Sun, Dong Sheng ^a   Yao, Lei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

hepatocellular carcinoma; ING4; miR 650

Indexed keywords

ING4 PROTEIN; MICRORNA; MICRORNA 650; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL VIABILITY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PARACARCINOMATOUS LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VOLUME; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELLS, CULTURED; DOWN-REGULATION; FEMALE; GENETIC MARKERS; HOMEODOMAIN PROTEINS; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84872270832     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23210     Document Type: Article

References (23)

1. Murray CJ, Lopez AD:, Mortality by cause for eight regions of the world: Global burden of disease study. Lancet 1997; 349: 1269-1276;.
2. Giannelli G, Antonaci S:, Novel concepts in hepatocellular carcinoma: From molecular research to clinical practice. J Clin Gastroenterol 2006; 40: 842-846;.
3. Farazi PA, DePinho RA:, Hepatocellular carcinoma pathogenesis: From genes to environment. Nat Rev Cancer 2006; 6: 674-687;.
4. Braconi C, Patel T:, MicroRNA expression profiling: A molecular tool for defining the phenotype of hepatocellular tumors. Hepatology 2008; 47: 1807-1809;.
5. Ladeiro Y, Couchy G, Balabaud C, et al.: MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008; 47: 1955-1963;.
6. Mott JL:, MicroRNAs involved in tumor suppressor and oncogene pathways: Implications for hepatobiliary neoplasia. Hepatology 2009; 50: 630-637;.
7. Zhang X, Zhu W, Zhang J, et al.: MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun 2010; 395: 275-280;.
8. Chan E, Patel R, Nallur S, et al.: MicroRNA signatures differentiate melanoma subtypes. Cell Cycle 2011; 10: 1845-1852;. Epub 2011 Jun 1.
9. Chien WW, Domenech C, Catallo R, et al.: Cyclin-dependent kinase 1 expression is inhibited by p16(INK4a) at the post-transcriptional level through the microRNA pathway. Oncogene 2011; 30: 1880-1891;. Epub 2010 Dec 20.
10. Greene FL, Page DL, Fleming ID, et al.: editors. AJCC cancer staging manual, 6th edition. Chicago: Springer-Verlag; 2002.
11. Huang S, He X:, The role of microRNAs in liver cancer progression. Br J Cancer 2011; 104: 235-240;. Epub 2010 Nov 23. Review.
12. Gramantieri L, Ferracin M, Fornari F, et al.: Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007; 67: 6092-6099;.
13. Shimizu S, Takehara T, Hikita H, et al.: The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 2010; 52: 698-704;.
14. Ding J, Huang S, Wu S, et al.: Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat Cell Biol 2010; 12: 390-399;.
15. Yao J, Liang L, Huang S, et al.: MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 2010; 51: 846-856;.
16. Li Feng, Yun Xie, Hao Zhang, et al.: Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650. Biochem Biophys Res Commun 2011; 406: 534-538;.
17. Russell M, Berardi P, Gong W, et al.: Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis. Exp Cell Res 2006; 312: 951-961;.
18. Qiu-shi Wang, Ming Li, Lin-you Zhang, et al.: Down-regulation of ING4 is associated with initiation and progression of lung cancer. Histopathology 2010; 57: 271-281;.
19. Gunduz M, Nagatsuka H, Demircan K, et al.: Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 2005; 356: 109-117;.
20. Ming Li, Yan Jin, Wen-jing Sun, et al.: Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma. J Pathol 2009; 219: 87-95;.
21. Garkavtsev I, Kozin SV, Chernova O, et al.: The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 2004; 428: 328-332;.
22. Kim S, Chin K, Gray JW, et al.: A screen for genes that suppress loss of contact inhibition: Identification of ING4 as a candidate tumor suppressor gene in human cancer. Proc Natl Acad Sci USA 2004; 101: 16251-16256;.
23. Fang F, Luo LB, Tao YM, et al.: Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2009; 18: 409-416;.